|
|
||||||||
Department of Microbiology, University of Tennessee, Knoxville, TN 37996
DNA vaccination has been widely studied in several models of vaccination and in the treatment of inflammatory diseases, even though the mechanism involved is still unclear. This report demonstrates that mucosal administration of plasmid DNA leads to rapid and widespread distribution around the body. Dissemination likely occurred via the bloodstream because plasmid DNA was present in blood plasma. The plasmid DNA was also detectable in several tissues including draining lymph nodes, spleen, liver, bone marrow, and even the dermis of ear pinnae. Except for the site of administration, plasmid DNA was no longer detectable in tissues after 3 wk postadministration. RNA and protein expression was also found in the tissues and bloodstream. Animals previously primed by HSV infection and subsequently given IL-10 DNA via the nasal mucosa, showed diminished Ag-induced delayed type hypersensitivity reactions for up to 5 wk posttreatment. The mechanism of modulation involved diminished the Ag-specific proliferation and production of Th1 cytokines. The Ag-specific silencing effects persisted beyond the duration of detectable plasmid encoded protein and was maintained upon adoptive transfer of T cells into a plasmid-free environment. The silenced T cells were not a source of IL-10, and their anergic state was reversible by exposure to Ag in the presence of exogenous IL-2.
This article has been cited by other articles:
![]() |
J. Zhang, N. Silvestri, J. L. Whitton, and D. E. Hassett Neonates Mount Robust and Protective Adult-Like CD8+-T-Cell Responses to DNA Vaccines J. Virol., October 25, 2002; 76(23): 11911 - 11919. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. del Pozo, M. Rojo, M. L. Rubio, I. Cortegano, B. Cardaba, S. Gallardo, M. Ortega, E. Civantos, E. Lopez, C. Martin-Mosquero, et al. Gene Therapy with Galectin-3 Inhibits Bronchial Obstruction and Inflammation in Antigen-challenged Rats through Interleukin-5 Gene Downregulation Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 732 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Southam, M. Dolovich, P. M. O'Byrne, and M. D. Inman Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L833 - L839. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Eo, U. Kumaraguru, and B. T. Rouse Plasmid DNA Encoding CCR7 Ligands Compensate for Dysfunctional CD8+ T Cell Responses by Effects on Dendritic Cells J. Immunol., October 1, 2001; 167(7): 3592 - 3599. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Gruener, F. Lechner, M.-C. Jung, H. Diepolder, T. Gerlach, G. Lauer, B. Walker, J. Sullivan, R. Phillips, G. R. Pape, et al. Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus J. Virol., June 15, 2001; 75(12): 5550 - 5558. [Abstract] [Full Text] |
||||
![]() |
D. J.J. Carr, P. Härle, and B. M. Gebhardt The Immune Response to Ocular Herpes Simplex Virus Type 1 Infection Experimental Biology and Medicine, May 1, 2001; 226(5): 353 - 366. [Abstract] [Full Text] |
||||
![]() |
S. K. Eo, M. Gierynska, A. A. Kamar, and B. T. Rouse Prime-Boost Immunization with DNA Vaccine: Mucosal Route of Administration Changes the Rules J. Immunol., May 1, 2001; 166(9): 5473 - 5479. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Harle, S. Noisakran, and D. J. J. Carr The Application of a Plasmid DNA Encoding IFN-{{alpha}}1 Postinfection Enhances Cumulative Survival of Herpes Simplex Virus Type 2 Vaginally Infected Mice J. Immunol., February 1, 2001; 166(3): 1803 - 1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Eo, S. Lee, S. Chun, and B. T. Rouse Modulation of Immunity against Herpes Simplex Virus Infection via Mucosal Genetic Transfer of Plasmid DNA Encoding Chemokines J. Virol., January 15, 2001; 75(2): 569 - 578. [Abstract] [Full Text] |
||||
![]() |
U. Kumaraguru, R. J. D. Rouse, S. K. Nair, B. D. Bruce, and B. T. Rouse Involvement of an ATP-Dependent Peptide Chaperone in Cross-Presentation After DNA Immunization J. Immunol., July 15, 2000; 165(2): 750 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kitani, I. J. Fuss, K. Nakamura, O. M. Schwartz, T. Usui, and W. Strober Treatment of Experimental (Trinitrobenzene Sulfonic Acid) Colitis by Intranasal Administration of Transforming Growth Factor (Tgf)-{beta}1 Plasmid: TGF-{beta}1-Mediated Suppression of T Helper Cell Type 1 Response Occurs by Interleukin (Il)-10 Induction and IL-12 Receptor {beta}2 Chain Downregulation J. Exp. Med., July 3, 2000; 192(1): 41 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Noisakran and D. J. J. Carr Plasmid DNA Encoding IFN-{alpha}1 Antagonizes Herpes Simplex Virus Type 1 Ocular Infection Through CD4+ and CD8+ T Lymphocytes J. Immunol., June 15, 2000; 164(12): 6435 - 6443. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |